Page last updated: 2024-10-26

dipyridamole and Cross Infection

dipyridamole has been researched along with Cross Infection in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Cross Infection: Any infection which a patient contracts in a health-care institution.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tonew, M1
Tonew, E1
Linde, P1
Stelzner, A1

Other Studies

1 other study available for dipyridamole and Cross Infection

ArticleYear
Dipyridamole (Curantyl, Antistenocardin) failed to induce interferon (IFN) in man.
    Acta virologica, 1989, Volume: 33, Issue:6

    Topics: Cells, Cultured; Cross Infection; Dipyridamole; Humans; Interferons; Vesicular stomatitis Indiana vi

1989